News Posts List
Malaria drug helps kidney cancer patien
01/31/2013
SAN ANTONIO - Five years, local attorney Henry Grun had his will ready to be executed at the request of his first oncologist, who warned him that his kidney cancer was so aggressive he had only six months to live.
Cerulean Pharma to Present Avastin®-CRLX101 Synergy Data
01/30/2013
Cerulean Pharma Inc., a leader in designing and developing dynamically tumor-targeted nanopharmaceuticals, today announced that Scott D. Eliasof, Ph.D, vice president of research, will present data on Cerulean’s most advanced experimental cancer treatment, CRLX101, at the 15th International Symposium on Anti-angiogenic Therapy.
AVEO, Astellas Announce Presentations of Tivozanib Clinical Data
01/30/2013
Astellas Pharma today announced that new clinical data on tivozanib, an investigational agent for the treatment of metastatic renal cell carcinoma (mRCC), will be presented at the 2013 American society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), taking place February 14-16 in Orlando, Florida.
Breneman named officer of PSU Uplfiting Athletes chapter
01/24/2013
Penn State freshman tight end Adam Breneman has been named an officer of Penn State's Uplifting Athletes chapter, the university announced.
Nephron Sparing Surgery For Papillary Renal Cell Carcinoma in Horseshoe Kidney
01/24/2013
The exact incidence of carcinoma in horseshoe kidney has not been described in literature but the observation has been made that it is higher - approximately 3 to 4 times greater than that of the rest of the population.
Communicate Effectively With Your Medical Team
01/24/2013
These videos are sponsored by AVEO Oncology and Astellas Oncology.
International Kidney Cancer Congress Clinical Trials App
01/24/2013
Get the newest kidney cancer clinical trials app for the Apple iPad and iPhone
Conquer Cancer Foundation Research Update
01/24/2013
The Conquer Cancer Foundation has recently communicated with our researchers on the progress they have made during the first six months of their grant term. We are delighted to share with you the update we received from Dr. Martin Voss, currently at work at the Sloan-Kettering Institute for Cancer Research, through the generous support of the Kidney Cancer Association.
News Feed